A trial to evaluate the safety of long term treatment with nintedanib in patients with scleroderma related lung fibrosis.
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 8, 2018
End Date
August 14, 2023
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Boehringer Ingelheim Pharmaceuticals, Inc.
Start Date
May 8, 2018
End Date
August 14, 2023